3-iodobenzylguanidine has been researched along with natriuretic peptide, brain in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 25 (71.43) | 29.6817 |
| 2010's | 9 (25.71) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| Aoki, S; Makino, K; Nomura, Y; Okamoto, R; Okamoto, S; Saitou, K; Takeda, K; Yahara, Y | 1 |
| Fukuyama, T; Imamura, Y; Miyagawa, M; Mochizuki, T; Watanabe, K | 1 |
| Fukushima, N; Horiguchi, K; Matsuda, H; Matsumiya, G; Miyagawa, S; Nishimura, M; Ohtake, S; Sawa, Y; Taketani, S | 1 |
| Hanatani, A; Hirooka, K; Hori, M; Ishida, Y; Komamura, K; Miyatake, K; Nakatani, S; Yamagishi, M; Yasumura, Y | 1 |
| Kinoshita, M; Matsui, T; Tsutamoto, T | 1 |
| Kinoshita, M; Kusukawa, J; Maeda, K; Matsui, T; Tsutamoto, T | 1 |
| Ashino, K; Ebina, T; Inoue, T; Ishigami, T; Ishikawa, Y; Kuji, N; Matsubara, S; Minamisawa, K; Mitani, I; Ochiai, H; Oka, T; Sumita, S; Takahashi, N; Umemura, S | 1 |
| Fukuda, N; Onose, Y; Sakabe, K; Shinohara, H; Soeki, T; Tamura, Y | 1 |
| Hashimoto, A; Kyuma, M; Nagao, K; Nakata, T; Sasao, H; Shimamoto, K; Takahashi, T; Tsuchihashi, K | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Bax, JJ; De Bruin, R; De Winter, RJ; Erol-Yilmaz, A; Hrudova, J; Schalij, MJ; Schrama, TA; Tukkie, R; Van Eck-Smit, BL; Verberne, HJ; Wilde, AA | 1 |
| Ando, A; Isobe, S; Iwase, M; Izawa, H; Kato, K; Murohara, T; Nagata, K; Nanasato, M; Nishizawa, T; Nonokawa, M; Ohshima, S; Yokota, M | 1 |
| Horie, M; Masuda, D; Matsumoto, T; Matsuo, S; Nakae, I | 1 |
| Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 2 |
| Hara, M; Nakagawa, M; Saikawa, T; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Arimoto, T; Hirono, O; Kitahara, T; Koyama, Y; Kubota, I; Niizeki, T; Nitobe, J; Nozaki, N; Okada, A; Suzuki, S; Takahashi, K; Takeishi, Y; Tsunoda, Y; Watanabe, T | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Sato, Y; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Ito, S; Kawano, T; Koshiba, K; Mikawa, J; Nada, T; Nomura, M | 1 |
| Hashimoto, A; Kyuma, M; Nagahara, D; Nakata, T; Noda, R; Shimamoto, K; Shimoshige, S; Tsuchihashi, K; Uno, K; Wakabayashi, T | 1 |
| Fujii, M; Horie, M; Nakae, I; Nishiyama, K; Ohnishi, M; Sakai, H; Tanaka, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Arimoto, T; Harada, M; Ikeno, E; Kubota, I; Nisugi, K; Sukekawa, H; Takayama, S; Takeishi, Y | 1 |
| Fujimoto, S; Fukunaga, S; Inoue, A; Nakanishi, R; Nakano, H; Namiki, A; Nanjo, S; Yamashina, S; Yamashiro, Y; Yamazaki, J | 1 |
| Bareiss, P; Blondet, C; Cimarelli, S; Constantinesco, A; De Poli, F; Imperiale, A; Jesel, L; Morel, O; Ohlmann, P; Sauer, F; Trinh, A | 1 |
| Despas, F; Galinier, M; Guerriero, E; Pathak, A; Senard, J | 1 |
| Athanasoulis, T; Diakos, N; Drakos, SG; Koudoumas, D; Malliaras, KG; Nanas, JN; Ntalianis, AS; Terrovitis, JV; Theodoropoulos, SP; Yacoub, MH | 1 |
| Agostini, D; Cerqueira, MD; Chandna, H; Jacobson, AF; Lopez, VA; Narula, J; Senior, R; Thomas, GS; Weiland, F; Wong, ND | 1 |
| Ando, S; Goto, Y; Kadota, J; Kawano, Y; Kotoku, M; Shinozaki, K; Tamura, A | 1 |
| Arimoto, T; Funayama, A; Ishino, M; Katoh, S; Kubota, I; Kutsuzawa, D; Miyamoto, T; Miyashita, T; Netsu, S; Niizeki, T; Nishiyama, S; Nitobe, J; Shishido, T; Takahashi, H; Watanabe, T | 1 |
| Campelo, M; Faria, T; Madureira, A; Martins, E; Oliveira, A; Pereira, JG; Pinho, T; Ramos, I; Ribeiro, O; Rocha-Gonçalves, F; Silva-Cardoso, J | 1 |
| Clements, IP; Hodge, DO; Jacobson, AF; Wiseman, GA | 1 |
| Jacobson, AF; Kasama, S; Matsui, T; Matsuo, S; Momose, M; Nakajima, K; Nakata, T; Travin, MI; Yamada, T; Yamashina, S | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Nakata, T; Sumino, H; Toyama, T | 1 |
| Henzlova, MJ; Jacobson, AF; Jain, D; Poel, E; Travin, MI; Verberne, HJ; Verschure, DO | 1 |
1 review(s) available for 3-iodobenzylguanidine and natriuretic peptide, brain
| Article | Year |
|---|---|
A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Biomarkers; Chi-Square Distribution; Databases as Topic; Disease Progression; Evidence-Based Medicine; Female; Heart; Heart Failure; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; ROC Curve; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 2013 |
11 trial(s) available for 3-iodobenzylguanidine and natriuretic peptide, brain
| Article | Year |
|---|---|
Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiomyopathies; Death; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Atrial Natriuretic Factor; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Propanolamines; Therapeutic Equivalency; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
Clinical implications of cardiac (123)I-meta-iodobenzylguanidine scintigraphy and cardiac natriuretic peptides in patients with heart disease.
Topics: 3-Iodobenzylguanidine; Angina Pectoris; Atrial Natriuretic Factor; Cardiomyopathies; Chronic Disease; Female; Follow-Up Studies; Heart Diseases; Heart Valve Diseases; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2002 |
Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiac Volume; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Stroke Volume; Tetrazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Function, Left | 2005 |
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Heart; Heart Failure; Humans; Male; Mediastinum; Middle Aged; Natriuretic Peptide, Brain; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Tetrazoles; Valine; Valsartan | 2006 |
Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Echocardiography; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Prospective Studies; Radiopharmaceuticals; Stroke Volume; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Remodeling | 2007 |
Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Synergism; Echocardiography; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Spironolactone; Sympathetic Nervous System; Tetrazoles; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Selection; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic peptide in patients with chronic heart failure: comparison with enalapril.
Topics: 3-Iodobenzylguanidine; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Enalapril; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Perindopril; Radionuclide Imaging; Risk Factors; Stroke Volume; Sympathetic Nervous System; Treatment Outcome | 2008 |
Short cardiac iodine-123-metaiodobenzylguanidine imaging protocol in heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Function, Left | 2008 |
Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Diagnostic Imaging; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Risk; Stroke Volume | 2010 |
23 other study(ies) available for 3-iodobenzylguanidine and natriuretic peptide, brain
| Article | Year |
|---|---|
Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adult; Aged; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart Ventricles; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Propanolamines; Radiopharmaceuticals; Recovery of Function; Retrospective Studies; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Function, Left | 2000 |
[Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Biomarkers; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Stroke Volume; Subtraction Technique | 2000 |
Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support.
Topics: 3-Iodobenzylguanidine; Adult; Atrial Natriuretic Factor; Cardiomyopathies; Echocardiography; Female; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2001 |
Relationship between cardiac 123I-metaiodobenzylguanidine imaging and the transcardiac gradient of neurohumoral factors in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Biological Transport, Active; Cardiomyopathy, Dilated; Female; Heart; Heart Failure; Hemodynamics; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments--comparison with neurohumoral factors.
Topics: 3-Iodobenzylguanidine; Cardiomyopathy, Dilated; Cardiotonic Agents; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate; Time Factors; Ventricular Function, Left | 2002 |
Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Creatinine; Echocardiography; Female; Heart; Heart Failure; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Potassium; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Angiotensin; Renin; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Diabetes Mellitus; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume | 2004 |
Cardiac resynchronization induces favorable neurohumoral changes.
Topics: 3-Iodobenzylguanidine; Cardiac Pacing, Artificial; Echocardiography, Doppler; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Echocardiography; Exercise Test; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Ventricular Function, Left | 2005 |
Dilated cardiomyopathy relieved as a result of beta-blocker therapy: a case report--key points in assessment of prognosis based on MIBG myocardial scintigraphy and BNP levels.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Follow-Up Studies; Humans; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Propanolamines; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System; Baroreflex; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart; Heart Conduction System; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Iodine Radioisotopes; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Radionuclide Imaging | 2006 |
Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2007 |
Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity.
Topics: 3-Iodobenzylguanidine; Adipokines; Aged; Antihypertensive Agents; Antioxidants; Arteriosclerosis; Autonomic Nervous System; Azetidinecarboxylic Acid; Calcium Channel Blockers; Cardiomegaly; Carotid Arteries; Catecholamines; Cytokines; Dihydropyridines; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Pulse; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Evaluation of sympathetic activity by 123I-metaiodobenzylguanidine myocardial scintigraphy in dilated cardiomyopathy patients with sleep breathing disorder.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiomyopathy, Dilated; Catecholamines; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Natriuretic Peptide, Brain; Oximetry; Oxygen; Radiography; Radiopharmaceuticals; Sleep; Sleep Apnea Syndromes; Sympathetic Nervous System | 2009 |
Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; C-Reactive Protein; Case-Control Studies; Catecholamines; Coronary Circulation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Leukocyte Count; Male; Myocardium; Natriuretic Peptide, Brain; Norepinephrine; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Troponin I | 2009 |
Limited prognostic value of cardiac metaiodobenzylguanidine in advanced heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Cause of Death; Disease-Free Survival; Exercise Test; Female; Heart; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen; Patient Selection; Prospective Studies; Radionuclide Imaging; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2010 |
Myocardial sympathetic innervation and long-term left ventricular mechanical unloading.
Topics: 3-Iodobenzylguanidine; Aged; Biomarkers; Creatinine; Female; Follow-Up Studies; Heart; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Pulmonary Wedge Pressure; Radiopharmaceuticals; Recovery of Function; Sodium; Stroke Volume; Sympathetic Nervous System; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Ventricular Function, Left; Young Adult | 2010 |
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
Topics: 3-Iodobenzylguanidine; Aged; Disease Progression; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Research Design; Risk Assessment; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2010 |
Washout rate of cardiac iodine-123 metaiodobenzylguanidine is high in chronic heart failure patients with central sleep apnea.
Topics: 3-Iodobenzylguanidine; Aged; Female; Health Status Indicators; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Polysomnography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Sleep Apnea, Central; Statistics, Nonparametric; Stroke Volume; Sympathetic Nervous System; Ventricular Function, Left | 2010 |
Meta-iodobenzylguanidine iodine-123 and cardiac adrenergic activity in familial dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Dilated; Contrast Media; Diagnostic Imaging; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Natriuretic Peptide, Brain; Organometallic Compounds; Prognosis; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left | 2010 |
Outcome prediction in heart failure with atrial fibrillation: relative role of left ventricular ejection fraction and neurohormonal measures.
Topics: 3-Iodobenzylguanidine; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Echocardiography; Female; Follow-Up Studies; Heart Failure; Hormones; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Proportional Hazards Models; Prospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2013 |
Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide.
Topics: 3-Iodobenzylguanidine; Administration, Intravenous; Aged; Aldosterone; Atrial Natriuretic Factor; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Organ Size; Radionuclide Imaging; Sympathetic Nervous System | 2014 |
A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure.
Topics: 3-Iodobenzylguanidine; Heart; Heart Failure; Humans; Iodine Radioisotopes; Natriuretic Peptide, Brain; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2022 |